Saturday, April 05, 2014 8:18:56 PM
http://www.reuters.com/article/2009/06/25/idUS225933+25-Jun-2009+PRN20090625
Did you mean this part? Looks like he knew there was a fundamental issue with KING back in 2009 and warned everyone in a PR!
Upon learning this, it just didn't sit well
with us. That action exposed us and these Companies to lawsuits from
dissenting shareholders, SEC inquiries, sanctions and other possible
liabilities that XXXX XXXXXXXX did not anticipate and did not bargain for.
"We are extremely disappointed that Belmont and Mr. Meuse (The X
management) simply refused to address these matters and other matters when
brought to their attention. Moreover there are other serious irregularities
that were discovered by our internal forensic research analysts that would
seriously undermine the rights of minority shareholders of these companies. In
addition any company that merged with these issuers would have been placed in
peril".
Im not a basher nor a pumper! Play your own hand!
Recent KRFG News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 03:37:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/14/2024 12:58:23 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/09/2024 06:51:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:09:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 04:17:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 03:13:58 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 12:23:44 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 10/16/2023 01:42:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 03:48:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 06:52:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM